Royal Bank Of Canada Tff Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.43 - $0.77 $58 - $105	137 New	137 $0
Q3 2022 Nov 14, 2022	BUY	$4.61 - $116.0 $525 - $13,224	114 Added 22.8%	614 $2,000
Q1 2022 May 16, 2022	SELL	$5.28 - $9.17 $84 - $146	-16 Reduced 3.1%	500 $3,000
Q4 2021 Feb 14, 2022	BUY	$6.86 - $9.65 $109 - $154	16 Added 3.2%	516 $4,000
Q3 2021 Nov 15, 2021	BUY	$7.21 - $10.49 $3,605 - $5,245	500 New	500 $4,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.